Diagnostic and prognostic imaging of the cardiac sympathetic nervous system

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue SUPPL. 2, 2008, Pages

  Link, Jeanne M ^a   Caldwell, James H ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 3 HYDROXYEPHEDRINE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 11; CGP 12388; METHYLQUINUCLIDINYL BENZILATE; NORADRENALIN; NORADRENALIN TRANSPORTER; TRACER;

ADRENERGIC SYSTEM; ARTICLE; CELL DENSITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEART DEATH; HEART EJECTION FRACTION; HEART HYPERTROPHY; HEART INNERVATION; HEART RATE VARIABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISOTOPE LABELING; MORTALITY; NORADRENALIN UPTAKE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY; SCINTILLATION CAMERA; SUDDEN DEATH; T WAVE;

CARDIOMYOPATHIES; HEART; HEART FAILURE; HUMANS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; PRESYNAPTIC TERMINALS; RECEPTORS, ADRENERGIC, BETA; SYMPATHETIC NERVOUS SYSTEM;

EID: 48349142569     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1150     Document Type: Article

References (50)

1. Wieland DM et al. (1981) Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22: 22-31
2. DeGrado TR et al. (2000) Tracer kinetic modeling in nuclear cardiology. J Nucl Cardiol 7: 686-700
3. Schwaiger M et al. (1990) Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 82: 457-464
4. Delforge J et al. (1991) Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 32: 739-748
5. Doze P et al. (2002) Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic model. Eur J Nucl Med Mol Imaging 29: 295-304
6. Syrota A et al. (1984) Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Life Sci 35: 937-945
7. Packer M (1992) The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 26: 248-254
8. Francis GS et al. (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729
9. Böhm M et al. (1995) Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25 146-153
10. Hasking G et al. (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73 615-621
11. Eisenhofer G et al. (1996) Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676
12. Merlet P et al. (1999) prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40: 917-923
13. Parthenakis FI et al. (2002) Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol 9: 15-22
14. Cohen-Solal A et al. (1999) Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 33: 759-766
15. Hartmann F et al. (1999) Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: An analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart 81: 262-270
16. Vesalainen RK et al. (1999) Cardiac positron emission tomography imaging with [11C] hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure. Am J Cardiol 84: 568-574
17. Link JM et al. (2003) PET measures of pre- and post-synaptic cardiac beta adrenergic function. Nucl Med Biol 30: 795-803
18. Merlet P et al. (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33: 471-477
19. Kyuma M et al. (2004) Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. J Nucl Med 45: 155-163
20. Nakata T et al. (2003) Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction. J Card Fail 9: 113-121
21. Chen J et al. (2006) Improved quantification in 123I cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun 27: 551-558
22. Gerson MC et al. (2003) Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J Card Fail 9: 384-391
23. Yamada T et al. (2003) Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study. J Am Coll Cardiol 41: 231-238
24. Arimoto T et al. (2007) Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. J Card Fail 13: 34-41
25. Nakata T et al. (1998) Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 5: 579-590
26. Wakabayashi T et al. (2001) Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 42: 1757-1767
27. Nakata T et al. (1998) Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 5: 579-590
28. Kioka H et al. (2007) Prediction of sudden death by using cardiac iodine-123 metaiodobenzylguanidine imaging in patients with mild to moderate chronic heart failure. Heart 93: 1213-1218
29. Mozaffarian D et al. (2007) Prediction of mode of death in heart failure: The Seattle Heart Failure Model. Circulation 116: 392-398
30. Pietila M et al. (2001) Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 28: 373-376
31. Fallavollita JA et al. (2006) Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods. Contemp Clin Trials 27: 374-388
32. Bristow MR et al. (1986) Beta 1- and beta 2- adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective b1-adrenoceptor down-regulation in heart failure. Circ Res 59 297-309
33. Merlet P et al. (1993) Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 87: 1169-1178
34. Ungerer M et al. (1998) Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 97: 174-180
35. Janka HU (1996) Increased cardiovascular morbidity and mortality in diabetes mellitus: Identification of the high risk patient. Diabetes Res Clin Pract 30 (suppl): S85-S88
36. Jouven X et al. (1999) Predicting sudden death in the population: the Paris Prospective Study I. Circulation 99: 1978-1983
37. Kim SJ et al. (1996) Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Eur J Nucl Med 23: 401-406
38. Muhr-Becker D et al. (1999) Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: One-year follow-up with improved metabolic control. Exp Clin Endocrinol Diabetes 107: 306-312
39. Stevens MJ et al. (1999) Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism 48: 92-101
40. Schnell O et al. (2002) Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy. J Diabetes Complications 16: 220-227
41. Pop-Busui R et al. (2004) Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 44: 2368-2374
42. Nagamachi S et al. (2006) Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol 13: 34-42
43. Schäfers M et al. (1998) Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 32: 181-186
44. Wichter T et al. (2000) Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 101: 1552-1558
45. Kies P et al. (2004) Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation 110: 3017-3022
46. Wichter T et al. (2002) Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105: 702-706
47. Paul M et al. (2006) Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 33: 866-870
48. Bengel FM and Schwaiger M (2004) Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 11: 603-616
49. Wamashina S and Yamazaki J (2007) Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 34 (suppl 1): S62-S73
50. Chen GP et al. (2005) Cardiac receptor physiology and imaging: An update. J Nucl Cardiol 12: 714-730